JP2015505831A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505831A5
JP2015505831A5 JP2014544964A JP2014544964A JP2015505831A5 JP 2015505831 A5 JP2015505831 A5 JP 2015505831A5 JP 2014544964 A JP2014544964 A JP 2014544964A JP 2014544964 A JP2014544964 A JP 2014544964A JP 2015505831 A5 JP2015505831 A5 JP 2015505831A5
Authority
JP
Japan
Prior art keywords
mutant
leukocidin
subunit
seq
subunit polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014544964A
Other languages
English (en)
Japanese (ja)
Other versions
JP6325452B2 (ja
JP2015505831A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/067483 external-priority patent/WO2013082558A1/en
Publication of JP2015505831A publication Critical patent/JP2015505831A/ja
Publication of JP2015505831A5 publication Critical patent/JP2015505831A5/ja
Application granted granted Critical
Publication of JP6325452B2 publication Critical patent/JP6325452B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014544964A 2011-12-02 2012-11-30 パントンバレンタインロイコシジン(pvl)由来ポリペプチドを含む免疫原性組成物 Active JP6325452B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161566234P 2011-12-02 2011-12-02
US61/566,234 2011-12-02
PCT/US2012/067483 WO2013082558A1 (en) 2011-12-02 2012-11-30 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides

Publications (3)

Publication Number Publication Date
JP2015505831A JP2015505831A (ja) 2015-02-26
JP2015505831A5 true JP2015505831A5 (enExample) 2016-01-28
JP6325452B2 JP6325452B2 (ja) 2018-05-16

Family

ID=48536149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014544964A Active JP6325452B2 (ja) 2011-12-02 2012-11-30 パントンバレンタインロイコシジン(pvl)由来ポリペプチドを含む免疫原性組成物

Country Status (13)

Country Link
US (1) US10023848B2 (enExample)
EP (1) EP2785368B1 (enExample)
JP (1) JP6325452B2 (enExample)
KR (1) KR101999299B1 (enExample)
AU (1) AU2012345645B2 (enExample)
CA (1) CA2857666C (enExample)
DK (1) DK2785368T3 (enExample)
ES (1) ES2728445T3 (enExample)
HR (1) HRP20190907T1 (enExample)
LT (1) LT2785368T (enExample)
RS (1) RS58919B1 (enExample)
SI (1) SI2785368T1 (enExample)
WO (1) WO2013082558A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857666C (en) 2011-12-02 2020-08-11 Integrated Biotherapeutics, Inc. Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides
CN110420316A (zh) 2013-06-18 2019-11-08 纽约大学 参与金黄色葡萄球菌杀白细胞素的细胞毒性的细胞因素:新型治疗靶点
CA2916231C (en) * 2013-06-19 2024-02-06 Integrated Biotherapeutics, Inc. Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
CN105873946A (zh) * 2013-10-17 2016-08-17 阿尔萨尼斯生物科学有限责任公司 交叉反应性金黄色葡萄球菌抗体序列
JP6620817B2 (ja) * 2015-08-10 2019-12-18 株式会社微生物化学研究所 黄色ブドウ球菌不活化菌体とロイコシジンを混合したワクチン
CN107224575B (zh) * 2017-03-06 2018-11-09 浙江海隆生物科技有限公司 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用
MX2020001046A (es) 2017-07-27 2020-08-06 Integrated Biotherapeutic Vaccines Inc Composicion inmunogenica que comprende un peptido de fusion derivado de toxoides de superantigenos.
WO2025085539A1 (en) * 2023-10-16 2025-04-24 The Trustees Of Columbia University In The City Of New York Engineered bacteria for cellular barrier maintenance and protection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20100158871A1 (en) 1999-08-30 2010-06-24 David Stephen Terman Sickled erythrocytes with antitumor molecules induce tumoricidal effects
US20050008633A1 (en) 2003-05-19 2005-01-13 Advanced Inhalation Research Inc. Chemical and physical modulators of bioavailability of inhaled compositions
MX2007015758A (es) * 2005-06-13 2008-02-22 Nabi Biopharmaceuticals Uso de leucocidina de panton-valentine para tratar y prevenir infecciones por estafilococos.
US7754225B2 (en) 2006-07-20 2010-07-13 Glaxosmithkline Biologicals S.A. Method of protecting against staphylococcal infection
EP2388593A3 (fr) * 2006-10-18 2012-01-18 bioMérieux Procédé de diagnostic in vitro des Staphylococcus aureus producteurs de PVL
CA2857666C (en) 2011-12-02 2020-08-11 Integrated Biotherapeutics, Inc. Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides

Similar Documents

Publication Publication Date Title
CA2873272C (en) Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof
JP7072921B2 (ja) A群レンサ球菌ワクチン
JP6325452B2 (ja) パントンバレンタインロイコシジン(pvl)由来ポリペプチドを含む免疫原性組成物
KR20210088535A (ko) 폐렴구균 융합 단백질 백신
ES2367128T3 (es) Procedimiento para preparar una variante del antígeno protector de superficie de erysipelothrix rhusiopathiae en e. coli.
US20250281591A1 (en) Staphylococcus aureus vaccine compositions
WO2022067255A2 (en) Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions
US10933126B2 (en) Clostridium difficile immunogenic compositions and methods of use
CN117355328A (zh) 金黄色葡萄球菌疫苗组合物
JP2021505525A (ja) A群レンサ球菌に対する免疫原性ペプチド
US20190276502A1 (en) Fusion polypeptides derived from staphylococcus aureus antigens
TW201347770A (zh) 致熱原性外毒素b胜肽疫苗
EP3535281A1 (en) Fusion polypeptides